A comparative study of spinal drug with and without adjuvant in patients undergoing below umbilical surgeries

A comparative study of 0.75% hyperbaric ropivacaine versus 0.75% hyperbaric ropivacaine with fentanyl on motor and sensory parameters in patients undergoing infraumbilical surgeries. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065142

Enrollment

Registered

2024-04-03

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: 0.75% Hyperbaric Ropivacaine for subarachnoid block: 2.7 ml of 0.75% Hyperbaric Ropivacaine with 0.3ml of saline used for subarachnoid block prior to infraumbilical surgeries. Drug will

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient who is willing to participate in the study 2. Patients undergoing infraumbilical surgeries 3. Patients belonging to Americal Society of Anaesthesiologist class 1, 2 and 3 4. Duration of surgery less than 2 hours

Exclusion criteria

Exclusion criteria: 1. Patient refusing to participate in the study 2. Patients with any contraindications for neuraxial blockade 3. Allergy to the study drug 4. Cardiogenic or hypovolemic shock 5. Respiratory insufficiency 6. Morbidly obese

Design outcomes

Primary

Measure	Time frame
The postoperative analgesic efficacy of subarachnoid block by visual analog scoreTimepoint: Postoperative analgesic efficacy assessed over 24 hours by visual analog score	—

Secondary

Measure	Time frame
Hemodynamic parameters Adverse effectsTimepoint: 24 hours	—

Countries

India

Contacts

Public ContactDr Samveda S G

BANGALORE MEDICAL COLLEGE AND RESEARCH INSTITUTE

Javidbeig@gmail.com9886444173

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026